End Cash: The amount of cash held by the company for the given period.
Innoveren Scientific, Inc. (IVRN) End Cash data is not available for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$0.45M |
|
$-10.30M |
|
$0.12M |
|
$0.34M |
|
$5.56M |
|
$-5.11M |
|
$-5.19M |
|
$-10.30M |
|
$-10.30M |
|
$-10.30M |
|
$-10.30M |
|
$-10.30M |
|
$-10.30M |
|
$-5.11M |
|
$-5.59M |
|
0.29M |
|
0.29M |
|
$-35.06 |
|
$-35.06 |
|
| Balance Sheet Financials | |
$0.08M |
|
$0.02M |
|
$0.05M |
|
$0.14M |
|
$7.48M |
|
-- |
|
$2.02M |
|
$9.49M |
|
$-9.80M |
|
$-9.36M |
|
$-9.36M |
|
0.62M |
|
| Cash Flow Statement Financials | |
$-1.91M |
|
$0.00M |
|
$1.82M |
|
$0.10M |
|
|
End Cash |
-- |
$-0.10M |
|
$0.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-- |
|
-0.41 |
|
74.07% |
|
-1125.96% |
|
-1125.96% |
|
-1232.89% |
|
-2271.33% |
|
-2271.33% |
|
$-1.91M |
|
-- |
|
-- |
|
-- |
|
3.30 |
|
-- |
|
15.39 |
|
23.72 |
|
105.14% |
|
110.07% |
|
-7498.40% |
|
110.07% |
|
$-15.12 |
|
$-6.51 |
|
$-6.51 |
|